065510.Kq
The company designs, develops, and sells medical equipment and technology, primarily serving the healthcare sector.
Business. The company designs, develops, and sells medical equipment and technology, primarily serving the healthcare sector.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company designs, develops, and sells medical equipment and technology, primarily serving the healthcare sector.
The company's capital structure is characterized by a debt-to-equity ratio of 0.73, indicating a moderate reliance on debt financing. However, its liquidity position is weak, with only 250 KRW in cash and equivalents and a negative free cash flow of -7,265,051,230 KRW. This is exacerbated by a negative net income of -4,973,820,460 KRW and an operating loss of -4,729,657,540 KRW, which together suggest a deteriorating financial position.
Profitability metrics are notably poor, with a return on equity of -4.71% and a return on assets of -2.21%. These figures fall significantly below the industry median for profitability, indicating that the company is underperforming its peers in terms of generating returns from its equity and asset base.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic or regulatory risks, though the exact geographic breakdown is not available in the current dataset.
The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current fiscal year. The operating cash flow of 12,661,205,390 KRW is insufficient to cover capital expenditures of -7,618,972,960 KRW, suggesting that the company is investing heavily in its operations but is not generating enough cash to sustain these investments without external financing.
Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is currently low, but the company's negative free cash flow and operating loss may necessitate future equity or debt financing, which could lead to share dilution. No specific dilution sources are identified in the available documents.
Recent events include a reported operating loss and a negative net income, as disclosed in the latest financial statements. No recent filings or transcripts have been provided that detail specific strategic or operational changes, but the financial performance suggests a challenging operating environment.
- The company is experiencing a significant operating loss and negative net income, indicating poor financial performance.
- The company's liquidity position is weak, with minimal cash and a negative free cash flow.
- The debt-to-equity ratio of 0.73 suggests a moderate reliance on debt, but the company's profitability is insufficient to support this leverage.
- The company's capital expenditures are not being funded by its operating cash flow, indicating a need for external financing.
- The company's financial performance is below industry medians for profitability and return metrics.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 065510.KQ Market data — financials · 2026-05-26
- Huvitz Co Ltd Market data — analyst estimates · 2026-05-26